| Quote | Spy MRK NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
52-Week High Club
DDS MRK SJM DBRN Linked by 24/7 Wall St. - November 20, 04:11PM from (247wallst.com) Dillard's Inc. (NYSE: DDS) rose as high as over 10% to a yearly high of $15.79 after the department-store chain was upgraded by Deutsche Bank AG. more ...
Latest Dividend Notes
MRK NKE ED Linked by The Dividend Daily - November 20, 12:26PM from (www.dividend.com) Here are some dividend-related notes from other sources around the web today. A quick peek at shares of dividend play Consolidated Edison (ED). more ...
Answering The Vytorin Question
ABT MRK PFE AZN Linked by Forbes - November 18, 06:13AM from (www.forbes.com) Merck scores a PR win at a cardiology conference, but that doesn't mean its cholesterol drugs are effective. more ...
52-Week High Club
MRK MSFT LNY FDX GOOG Linked by 24/7 Wall St. - November 16, 04:02PM from (247wallst.com) FedEX Corp. (NYSE: FDX) over 3% to a yearly high of $84.92. Barron's reported that the package delivery company may rise more ...
Retail Sales Spark Rally
TGT MRK WMT CSCO Linked by Forbes - November 16, 10:13AM from (www.forbes.com) Rebound for automakers fuels October rise; GM reports $1.2B Q3 loss, says it will start paying back taxpayers. more ...
Billionaire Paulson Bets Big on Gold, Citi
MRK BAC PEP PFE KGC JAVA C GS AU PBG GFI GLD ORCL Linked by tickerspy blog - November 16, 09:14AM from (www.tickerspy.com) John Paulson, the most successful, high-profile hedge fund manager of the last several years maintained a massive position more ...
Another Vytorin Mess For Merck
ABT BMY MRK PFE SGP AZN Linked by Forbes - November 15, 06:43PM from (www.forbes.com) A new study, though flawed, inflicts more damage on the company's Zetia and Vytorin cholesterol pills. more ...
Layoffs Sting Big Pharma
WYE BMY LLY MRK PFE JNJ GSK Linked by Forbes - November 13, 06:13AM from (www.forbes.com) Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen. more ...
Chasing Value: Ten stocks for 2010 -- Part 2
BA GE MRK WFC APC AAUKY DEO EZPW GS AEO BNI ISRG NLY BRK.B CMCSA BRK.A Linked by BloggingStocks - November 12, 03:00PM from (www.bloggingstocks.com) The clock is ticking away the time before the year ends and I have only begun to sort out the possibilities. In Part 1 of more ...
Analyst upgrades, downgrades and initiations: ARO, AZN, BNI, BRCD, HBC, MRK, TIF ...
HPQ MRK TIF COMS BKE AZN CWCO RWT BNI BRCD NUS HBC DNDN MBT SNY FLO GSK BAYRY ARO TLP HGG RHIE Linked by BloggingStocks - November 12, 11:00AM from (www.bloggingstocks.com) Analyst upgrades: Goldman upgraded Aeropostale (ARO) to neutral from sell. The firm, which has a $34 target more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|